Posts tagged with ‘marine natural product’

  • Scripps Scientist Cultivates U.S.-China Research Collaborations in Marine Biotechnology

    Science diplomat Bill Gerwick and his Chinese colleague orchestrate symposia that stimulate new joint research initiatives, personal connections. A casual dinner conversation at a scientific conference in Strömstad, Sweden two-and-a-half years ago about the astonishingly sparse interactions between scientists in the U.S. and China in the fields of marine biotechnology and marine natural products has evolved into a new collaborative […]
    0
  • Odyssey Marine Exploration and Morphogenesis discover biotech ‘treasures’ in the deep

    Researchers at biotech firm Morphogenesis have identified marine microorganisms that will yield critical pharmaceuticals such as anti-cancer drugs and antibiotics from seafloor sediment samples harvested by Odyssey. Morphogenesis Inc., a leading biotechnology and cancer-treatment research and development firm, has discovered substances with pharmaceutical properties beneficial to mankind from seafloor sediment samples that were recovered from the ocean bottom by Odyssey Marine […]
    0
  • First Transnational Joint Call for Research Projects: Marine Biotechnology ERA-NET

    Announcing the first transnational joint call for research projects within the framework of the Marine Biotechnology ERA-NET (ERA-MarineBiotech), which aims to coordinate European funding for marine biotechnology research, development and innovation. The main purpose of the call is to stimulate joint European research and development activities in marine biotechnology. The topic of the first transnational call is “The development of biorefinery processes […]
    0
  • Agile Nabs $1.5M NIH Grant for CF Therapy from Sea Sponge

    Raleigh biotechnology company Agile Sciences has landed a $1.5 million National Institutes of Health grant to help develop its cystic fibrosis therapy derived from sea sponges. Agile was spun out of North Carolina State University with the help of a $30,000 startup loan from the North Carolina Biotechnology Center. The company’s technology platform capitalizes on a chemical produced by the sea sponge to […]
    0
  • FAO review highlights food and feed uses for fish and shellfish by-products

    By-products may constitute as much as 70% of fish and shellfish after industrial processing and much focus has been on converting these into commercial products. The aim of this paper is therefore to evaluate important challenges and to consider the most realistic options in the use of by-products. Certain by-products like heads, frames and off-cuts from filleting of fish may […]
    0
  • Icelandic Collaboration for GlycoMar Limited with Lumpfish Byproducts

    Scottish biotechnology company GlycoMar, Icelandic marine biotechnology company Biopol and the University of University of Akureyri are pleased to announce their research collaboration. The consortium, led by Biopol, has received grant support from the AVS R&D Fund of Ministry of Fisheries in Iceland to evaluate the commercial viability of production of high value nutraceutical products from lumpfish. In this project, […]
    0
  • Mar. Drugs, Volume 12, Issue 5 (May 2014), Pages 2341-3090 Now Available

    MDPI is pleased to announce the publication of the following issue: Mar. Drugs, Volume 12, Issue 5 (May 2014), Pages 2341-3090 More info
    0
  • GlycoMar secures £ 890,000 investment

    Scottish marine biotechnology company GlycoMar Ltd has secured investment of £890,000 from new and existing investors. The investment is being used to progress the company’s anti-­‐inflammatory drug development programme. GlycoMar Limited was established in February 2005 and has its premises at the European Centre for  Marine Biotechnology, near Oban, Scotland. GlycoMar, which means ‘sweet sea’, is dedicated to the discovery, development […]
    0
  • U.S. leads the way for marine biotechnology

    Marine biotechnology is in growing demand in the cosmetics industry among others and it turns out the U.S. market has the largest share. More info
    0
  • Mar. Drugs, Volume 12, Issue 1 (January 2014), Pages 1-567 now available

    MDPI is pleased to announce the publication of the following issue: Mar. Drugs, Volume 12, Issue 1 (January 2014), Pages 1-567 http://www.mdpi.com/1660-3397/12/1/
    0